Here are four things to know.
1. The single-center, minimally invasive study evaluated the safety and efficacy of the Luna device when placed from a standard minimally invasive transforaminal lumbar interbody fusion approach.
2. The retrospective analysis assessed 31 patients treated with the Luna 3D System who had at least six months of postoperative follow up. All but one patient experienced improvement in baseline pain scores and disability scores improved for all patients. Spondylolisthesis was reduced significantly when present. There were no instances of graft subsidence or hardware failure.
3. The Luna 3D System is comprised of a PEEK implant intended to expand in multiple dimensions within the disc space, first in footprint, second in height and third in lordosis, enabling surgeons to restore sagittal balance and height through a MIS posterior approach while providing the stability of a larger construct usually associated with an anterior approach.
4. Post-discectomy, the Luna 3D Implant is delivered through a small diameter cannula into the disc space. After expanding its footprint, it then expands in height and lordosis with the insertion of a middle section. When the cannula is removed, a large volume of bone graft is placed in the middle of the implant to enable an interbody fusion.
More articles on surface technology:
5 spine surgeons on the future of implant technology & material
Amedica earns FDA clearance for Valeo C+CSC with Lumen Interbody Fusion Device — 5 notes
Stryker receives FDA clearance for 3-D printed tritanium lumbar cage: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.